Durrani K, Kempen J, Foster S, Group SITED (SITE) R. Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation". Ocul Immunol Inflamm. 2017;:1. See also: Infectious Disease, October 2017, All, 2017 Last updated on 03/06/2023
